Spin-orbit interaction and asymmetry effects on Kondo ridges at finite magnetic field

We study electron transport through a serial double quantum dot with Rashba spin-orbit interaction (SOI) and Zeeman field of amplitude B in presence of local Coulomb repulsion. The linear conductance as a function of a gate voltage Vg equally shifting the levels on both dots shows two B=0 Kondo ridges which are robust against SOI as time-reversal symmetry is preserved. Resulting from the crossing of a spin-up and a spin-down level at vanishing SOI two additional Kondo plateaus appear at finite B. They are not protected by symmetry and rapidly vanish if the SOI is turned on. Left-right asymmetric level-lead couplings and detuned on-site energies lead to a simultaneous breaking of left-right and bonding-anti-bonding state symmetry. In this case the finite-B Kondo ridges in the Vg-B plane are bent with respect to the Vg-axis. For the Kondo ridge to develop different level renormalizations must be compensated by adjusting B.Comment: 8 pages, 5 figures, revised version as publishe

Interplay of Coulomb interaction and spin-orbit effects in multi-level quantum dots

We study electron transport through a multi-level quantum dot with Rashba spin-orbit interaction in the presence of local Coulomb repulsion. Motivated by recent experiments, we compute the level splitting induced by the spin-orbit interaction at finite Zeeman fields $B$, which provides a measure of the renormalized spin-orbit energy. This level splitting is responsible for the suppression of the Kondo ridges at finite $B$ characteristic for the multi-level structure. In addition, the dependence of renormalized $g$-factors on the relative orientation of the applied $B$ field and the spin-orbit direction following two different protocols used in experiments is investigated.Comment: 11 pages, 13 figure

Comparison of Biomarkers in Blood and Saliva in Healthy Adults

Researchers measure biomarkers as a reflection of patient health status or intervention outcomes. While blood is generally regarded as the best body fluid for evaluation of systemic processes, substitution of saliva samples for blood would be less invasive and more convenient. The concentration of specific biomarkers may differ between blood and saliva. The objective of this study was to compare multiple biomarkers (27 cytokines) in plasma samples, passive drool saliva samples, and filter paper saliva samples in 50 healthy adults. Demographic data and three samples were obtained from each subject: saliva collected on filter paper over 1 minute, saliva collected by passive drool over 30 seconds, and venous blood (3 mL) collected by venipuncture. Cytokines were assayed using Bio-Rad multiplex suspension array technology. Descriptive statistics and pairwise correlations were used for data analysis. The sample was 52% male and 74% white. Mean age was 26 (range = 19–63 years, sd = 9.7). The most consistent and highest correlations were between the passive drool and filter paper saliva samples, although relationships were dependent on the specific biomarker. Correlations were not robust enough to support substitution of one collection method for another. There was little correlation between the plasma and passive drool saliva samples. Caution should be used in substituting saliva for blood, and relationships differ by biomarker

Head Position in Stroke Trial (HeadPoST)- sitting-up vs lying-flat positioning of patients with acute stroke: study protocol for a cluster randomised controlled trial

Background Positioning a patient lying-flat in the acute phase of ischaemic stroke may improve recovery and reduce disability, but such a possibility has not been formally tested in a randomised trial. We therefore initiated the Head Position in Stroke Trial (HeadPoST) to determine the effects of lying-flat (0°) compared with sitting-up (≥30°) head positioning in the first 24 hours of hospital admission for patients with acute stroke. Methods/Design We plan to conduct an international, cluster randomised, crossover, open, blinded outcome-assessed clinical trial involving 140 study hospitals (clusters) with established acute stroke care programs. Each hospital will be randomly assigned to sequential policies of lying-flat (0°) or sitting-up (≥30°) head position as a ‘business as usual’ stroke care policy during the first 24 hours of admittance. Each hospital is required to recruit 60 consecutive patients with acute ischaemic stroke (AIS), and all patients with acute intracerebral haemorrhage (ICH) (an estimated average of 10), in the first randomised head position policy before crossing over to the second head position policy with a similar recruitment target. After collection of in-hospital clinical and management data and 7-day outcomes, central trained blinded assessors will conduct a telephone disability assessment with the modified Rankin Scale at 90 days. The primary outcome for analysis is a shift (defined as improvement) in death or disability on this scale. For a cluster size of 60 patients with AIS per intervention and with various assumptions including an intracluster correlation coefficient of 0.03, a sample size of 16,800 patients at 140 centres will provide 90 % power (α 0.05) to detect at least a 16 % relative improvement (shift) in an ordinal logistic regression analysis of the primary outcome. The treatment effect will also be assessed in all patients with ICH who are recruited during each treatment study period. Discussion HeadPoST is a large international clinical trial in which we will rigorously evaluate the effects of different head positioning in patients with acute stroke. Trial registration ClinicalTrials.gov identifier: NCT02162017 (date of registration: 27 April 2014); ANZCTR identifier: ACTRN12614000483651 (date of registration: 9 May 2014). Protocol version and date: version 2.2, 19 June 2014

Níveis de lisina digestível em rações, em que se manteve ou não a relação aminoacídica, para frangos de corte de 1 a 21 dias de idade, mantidos em estresse por calor

Dois ensaios foram conduzidos para avaliar os efeitos de níveis de lisina digestível em rações em que se manteve ou não a relação aminoacídica sobre o desempenho de frangos de corte machos de 1 a 21 dias de idade, criados em alta temperatura. O delineamento experimental utilizado em ambos os ensaios foi o inteiramente casualizado. As aves, no ensaio 1, foram distribuídas em cinco tratamentos (0,92; 0,98; 1,04; 1,10 e 1,16% de lisina digestível em ração convencional), oito repetições e dez aves por repetição. No ensaio 2, os frangos foram distribuídos em quatro tratamentos (1,04; 1,10; 1,16 e 1,22% de lisina digestível em rações mantendo a relação aminoacídica), oito repetições e dez aves por repetição. No ensaio 1, os tratamentos influenciaram quadraticamente o ganho de peso e o consumo de ração, que aumentaram até os níveis de 1,14 e 1,09% de lisina, respectivamente. Embora a conversão alimentar tenha melhorado de forma linear, o modelo LRP foi o que melhor se ajustou aos dados, estimando em 1,097% o nível de lisina a partir do qual ocorreu um platô. Não houve efeito dos tratamentos sobre os pesos absolutos do coração, fígado e intestinos, enquanto o peso absoluto da moela aumentou linearmente. O peso absoluto da carcaça aumentou, enquanto os pesos relativos do coração e do fígado reduziram quadraticamente com os tratamentos. No ensaio 2, os tratamentos influenciaram de forma linear crescente o ganho de peso e a conversão alimentar, enquanto o consumo de ração não variou. Os tratamentos influenciaram linearmente o peso absoluto da carcaça, enquanto os pesos absoluto e relativo das vísceras não variaram. Concluiu-se que frangos de corte machos, de 1 a 21 dias de idade, mantidos em estresse por calor, exigem, no mínimo, 1,14 e 1,22% de lisina digestível em ração convencional e em ração em que se manteve a relação aminoacídica, respectivamente.Two trials were conducted to evaluate the effects of digestible lysine levels in diets maintaining or not the relationship of amino acids, on performance of broilers from 1 to 21 days, kept under heat stress. A completely randomized experimental design was used in both trials. In the trial 1, the broilers were allotted in five treatments (0.92; 0.98; 1.04; 1.10 and 1.16% of lysine in conventional diets), eight replicates and ten broilers per replicate. In the trial 2, the broilers were allotted in four treatments (1.04; 1.10; 1.16 and 1.22% of lysine in diet maintaining the relationship of amino acids), eight replicates and ten broilers per replicate. In the trial 1, the digestible lysine levels influenced quadraticly the weight gain and the feed intake that increased up to 1.14 and 1.09%, respectively. Although feed:gain ratio had changed by linear way, the LRP model adjusted better to the data, estimating in 1.097% the lysine level where occurred a "plateau". There was no effect of treatments on absolute weights of heart, liver and intestines, while the absolute weight of gizzard increased linearly. The absolute weight of carcass increased while the relative weights of heart and liver reduced quadraticly. In the trial 2, the treatments influenced in a crescent linear way the weight gain and the feed:gain ratio while the feed intake was not influenced. The treatments influenced linearly the absolute weight of carcass while the absolute and relative weights of the organs were not influenced. It was concluded that male broilers, in the period from 1 to 21 days of age, kept under heat stress, require at least 1.14 and 1.22% of digestible lysine in conventional diet and in diet maintaining the relationship of amino acid, respectively

The BARRIERS scale -- the barriers to research utilization scale: A systematic review

<p>Abstract</p> <p>Background</p> <p>A commonly recommended strategy for increasing research use in clinical practice is to identify barriers to change and then tailor interventions to overcome the identified barriers. In nursing, the BARRIERS scale has been used extensively to identify barriers to research utilization.</p> <p>Aim and objectives</p> <p>The aim of this systematic review was to examine the state of knowledge resulting from use of the BARRIERS scale and to make recommendations about future use of the scale. The following objectives were addressed: To examine how the scale has been modified, to examine its psychometric properties, to determine the main barriers (and whether they varied over time and geographic locations), and to identify associations between nurses' reported barriers and reported research use.</p> <p>Methods</p> <p>Medline (1991 to September 2009) and CINHAL (1991 to September 2009) were searched for published research, and ProQuest^®digital dissertations were searched for unpublished dissertations using the BARRIERS scale. Inclusion criteria were: studies using the BARRIERS scale in its entirety and where the sample was nurses. Two authors independently assessed the study quality and extracted the data. Descriptive and inferential statistics were used.</p> <p>Results</p> <p>Sixty-three studies were included, with most using a cross-sectional design. Not one study used the scale for tailoring interventions to overcome identified barriers. The main barriers reported were related to the setting, and the presentation of research findings. Overall, identified barriers were consistent over time and across geographic locations, despite varying sample size, response rate, study setting, and assessment of study quality. Few studies reported associations between reported research use and perceptions of barriers to research utilization.</p> <p>Conclusions</p> <p>The BARRIERS scale is a nonspecific tool for identifying general barriers to research utilization. The scale is reliable as reflected in assessments of internal consistency. The validity of the scale, however, is doubtful. There is no evidence that it is a useful tool for planning implementation interventions. We recommend that no further descriptive studies using the BARRIERS scale be undertaken. Barriers need to be measured specific to the particular context of implementation and the intended evidence to be implemented.</p